Dr. Abidi Pharmaceutical Laboratories (DABID) monthly reports
The company's monthly activity report on Codal: production and sales, raw materials, energy and foreign currency
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Unit | To 1405/06/31 | To 1405/05/31 | To 1405/04/31 | To 1405/03/31 | To 1405/02/31 | To 1405/01/31 |
|---|---|---|---|---|---|---|---|
| Tablets | million rials | 32,877,030 | 23,911,865 | 14,510,162 | 21,529,857 | 21,667,466 | 12,894,890 |
| Capsules | million rials | 6,853,667 | 7,065,095 | 5,344,037 | 5,637,052 | 4,681,438 | 1,400,778 |
| Syrup and suspension | million rials | 1,048,081 | 731,484 | 460,327 | 710,632 | 494,535 | 455,178 |
| Other | million rials | 28,677,127 | 7,054,729 | 7,049,802 | 7,877,582 | 6,119,005 | 3,281,931 |
| Discounts | million rials | -13,837,963 | -6,446,418 | -4,397,118 | -3,960,006 | -2,893,719 | -851,075 |
| Total domestic sales | million rials | 69,455,905 | 38,763,173 | 27,364,328 | 35,755,123 | 32,962,444 | 18,032,777 |
| Total | million rials | 55,617,942 | 32,316,755 | 22,967,210 | 31,795,117 | 30,068,725 | 17,181,702 |
| Total export sales | million rials | - | - | - | - | - | - |
Reporting periods
120 periods are on file for this report, from the period ending 1395/07/30 to the period ending 1405/06/31.